ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
47 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
1.0K
|
499K
|
47
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
LeftYahoo
|
299 |
141K |
179 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
141K
|
179
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
97 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
1.0K
|
499K
|
97
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
LeftYahoo
|
5.9K |
2.9M |
129 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
5.9K
|
2.9M
|
129
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
LeftYahoo
|
5.9K |
2.9M |
254 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
5.9K
|
2.9M
|
254
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
LeftYahoo
|
425 |
193K |
4 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
425
|
193K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
LeftYahoo
|
425 |
193K |
107 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
425
|
193K
|
107
|
|
ASX - By Stock
|
MSB |
Re:
What the hell is Convalescent plasma therapy
|
|
LeftYahoo
|
41 |
19K |
112 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
41
|
19K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
Chances of Covid Trial being a success
|
|
LeftYahoo
|
101 |
56K |
115 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
101
|
56K
|
115
|
|
ASX - By Stock
|
MSB Medicine |
Re:
To many threads
|
|
LeftYahoo
|
21 |
7.5K |
95 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
21
|
7.5K
|
95
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.0M |
48 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.0M |
116 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
116
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
LeftYahoo
|
2.0K |
701K |
32 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
2.0K
|
701K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
LeftYahoo
|
2.0K |
701K |
117 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
701K
|
117
|
|
ASX - By Stock
|
MSB |
Re:
COVID ARDS interim analysis
|
|
LeftYahoo
|
37 |
20K |
149 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
37
|
20K
|
149
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
LeftYahoo
|
248 |
94K |
142 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
248
|
94K
|
142
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
LeftYahoo
|
248 |
94K |
100 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
248
|
94K
|
100
|
|
ASX - By Stock
|
MSB |
Re:
Investors in MSB / MESO competitors research us
|
|
LeftYahoo
|
48 |
28K |
16 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
48
|
28K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Investors in MSB / MESO competitors research us
|
|
LeftYahoo
|
48 |
28K |
36 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
48
|
28K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.0M |
29 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
18K
|
7.0M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Investors in MSB / MESO competitors research us
|
|
LeftYahoo
|
48 |
28K |
42 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
48
|
28K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Investors in MSB / MESO competitors research us
|
|
LeftYahoo
|
48 |
28K |
71 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
48
|
28K
|
71
|
|
ASX - By Stock
|
MSB |
Re:
Investors in MSB / MESO competitors research us
|
|
LeftYahoo
|
48 |
28K |
174 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
48
|
28K
|
174
|
|
ASX - By Stock
|
MSB |
Re:
ARDS Trial - From UPenn Principal Investigator
|
|
LeftYahoo
|
41 |
26K |
108 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
41
|
26K
|
108
|
|
ASX - By Stock
|
MSB |
Re:
Countdown to Interim Analysis
|
|
LeftYahoo
|
195 |
72K |
48 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
195
|
72K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Countdown to Interim Analysis
|
|
LeftYahoo
|
195 |
72K |
48 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
195
|
72K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Countdown to Interim Analysis
|
|
LeftYahoo
|
195 |
72K |
42 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
195
|
72K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
95 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
1.0K
|
499K
|
95
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
22 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
1.0K
|
499K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
63 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
1.0K
|
499K
|
63
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
199 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
1.0K
|
499K
|
199
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
89 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
1.0K
|
499K
|
89
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
97 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
1.0K
|
499K
|
97
|
|
ASX - By Stock
|
MSB |
Re:
Head Scratchers
|
|
LeftYahoo
|
13 |
8.7K |
64 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
13
|
8.7K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
34 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
136 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
136
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
46 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
46
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
56 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
56
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
135 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
135
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
25 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
37 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
41 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
57 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
160 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
160
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
38 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
38
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
93 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
93
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
21 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
50 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
32 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
499K |
33 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
1.0K
|
499K
|
33
|
|